Chanrx Corp. moved a step closer to the goal line for lead candidate vanoxerine (GBR-12909), reporting Phase IIb data at the American Heart Association (AHA) 2013 Scientific Sessions suggesting the ...
Omaha, NE - The results of a recent study have shown a trend toward a lower rate of early atrial fibrillation (AF) recurrence at 24 hours after direct-current (DC) cardioversion in patients receiving ...
Mayo Clinic researchers report that the risk of stroke that sometimes results from a common treatment for atrial fibrillation can be minimized when the patient takes anticoagulation medication prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback